Guoping Zheng Selected Research

ICG 001

1/2021	Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β1.
1/2021	Promotion of β-Catenin/Forkhead Box Protein O Signaling Mediates Epithelial Repair in Kidney Injury.
10/2019	Fate alteration of bone marrow-derived macrophages ameliorates kidney fibrosis in murine model of unilateral ureteral obstruction.
1/2018	Redirecting TGF-β Signaling through the β-Catenin/Foxo Complex Prevents Kidney Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guoping Zheng Research Topics

Disease

17	Fibrosis (Cirrhosis) 01/2021 - 07/2004
13	Inflammation (Inflammations) 01/2022 - 04/2005
7	Chronic Renal Insufficiency 01/2016 - 02/2006
5	Nephrosis 10/2013 - 04/2005
4	Sepsis (Septicemia) 01/2022 - 01/2017
3	Sclerosis 01/2022 - 04/2005
3	Proteinuria 01/2022 - 06/2005
3	Reperfusion Injury 01/2021 - 01/2018
3	Acute Lung Injury 01/2020 - 04/2014
3	Lung Injury 01/2020 - 04/2014
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019 - 01/2013
2	Glomerulonephritis 01/2022 - 01/2019
2	Airway Remodeling 01/2021 - 01/2017
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2011
2	Asthma (Bronchial Asthma) 01/2021 - 01/2017
2	Ischemia 01/2021 - 01/2016
2	Infections 01/2020 - 01/2016
2	Ureteral Obstruction 11/2019 - 10/2019
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2019 - 06/2008
2	Kidney Diseases (Kidney Disease) 01/2018 - 01/2016
2	Nephritis 01/2014 - 01/2013
2	Neoplasms (Cancer) 01/2013 - 01/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 02/2006
2	Atrophy 05/2012 - 03/2010
1	Carotid Artery Diseases 01/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Anemia 10/2021
1	Hypoproteinemia 10/2021
1	Brain Diseases (Brain Disorder) 11/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2018
1	Non-alcoholic Fatty Liver Disease 09/2018
1	Eosinophilia 01/2017
1	Bronchiolitis 01/2017
1	Weight Loss (Weight Reduction) 01/2016
1	Pulmonary Edema 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Tetanus 02/2013
1	Virus Diseases (Viral Diseases) 01/2013

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2022 - 06/2010
9	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 04/2005
8	CateninsIBA 01/2021 - 01/2011
6	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2018
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2005
5	AntigensIBA 01/2019 - 01/2013
4	Cadherins (E-Cadherin)IBA 01/2021 - 01/2011
4	ICG 001IBA 01/2021 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2006
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2017
4	DNA VaccinesIBA 01/2019 - 02/2006
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
3	LipopolysaccharidesIBA 01/2020 - 05/2012
3	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 03/2010
3	CreatinineIBA 05/2012 - 06/2005
2	Interleukin-33IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 10/2019 - 01/2017
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016 - 04/2013
2	ChemokinesIBA 04/2009 - 06/2005
1	Immunoglobulin A (IgA)IBA 01/2022
1	B-Cell Activating FactorIBA 01/2022
1	human MIRN128 microRNAIBA 01/2022
1	Biological ProductsIBA 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	AlbuminsIBA 10/2021
1	TCF Transcription FactorsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	MitogensIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 10/2019
1	VaccinesIBA 01/2019
1	Estrogen Receptor alphaIBA 09/2018
1	CholesterolIBA 09/2018
1	oxidized low density lipoproteinIBA 09/2018
1	Dialysis SolutionsIBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2017
1	Dinoprostone (PGE2)FDA Link 01/2017
1	IntegrinsIBA 01/2016
1	integrin-linked kinaseIBA 01/2016
1	insulin-like growth factor binding protein-related protein 1IBA 01/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	U 0126 (UO 126)IBA 01/2015
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 04/2014
1	Interleukin-8 (Interleukin 8)IBA 04/2014
1	Interleukin-6 (Interleukin 6)IBA 04/2014
1	OsteopontinIBA 04/2013
1	Single-Chain AntibodiesIBA 02/2013

Therapy/Procedure

2	Ligation 01/2020 - 11/2019
2	Kidney Transplantation 01/2018 - 01/2016
1	Punctures 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2018
1	Immunotherapy 01/2018
1	Therapeutics 01/2017
1	Lung Transplantation 01/2017
1	Transplantation 01/2016